IN8Bio Competitors and Similar CompaniesClear all
IN8Bio's competitors and similar companies include FORMA Therapeutics.
 IN8Bio IN8Bio (formerly known as Innatus Therapeutics, Incysus Therapeutics) is a clinical-stage biopharmaceutical company focused on the development of gamma-delta T cell therapies for the treatment of cancer. |  FORMA Therapeutics FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines. | |
Founding Date | Founding Date 2016 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New York, US HQ Birmingham, US | Locations Watertown, US HQ |
Employees | Employees 13 | Employees 77 |
Valuation ($) | Valuation ($) 19.9 m | Valuation ($) 998.7 m |
Financial | ||
Net income | Net income ($19.4m) (FY, 2025) | Net income ($173m) (FY, 2021) |
Funding | ||
Total funding raised | Total funding raised $ 35m | Total funding raised $ 142.5m |
For sources of this data, please see the company profile
View Company Profiles
FORMA Therapeutics
HQ
Watertown, US
Employees
77
FORMA Therapeutics is a biopharmaceutical company intended for the discovery, development, and commercialization of transformative medicines.
View company